Document is current
Any future updates will be listed below
-
Authors
Eftekhari, Ashkan https://orcid.org/0000-0003-2871-8279
Westra, Jelmer
Stegehuis, Valérie
Holm, Niels Ramsing https://orcid.org/0000-0002-2316-3107
van de Hoef, Tim P
Kirkeeide, Richard L
Piek, Jan J
Lance Gould, K
Johnson, Nils P
Christiansen, Evald Høj
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02328820 at ClinicalTrials.govnct02328820 at ClinicalTrials.govDocuments that mention this clinical trial
Prognostic value of microvascular resistance and its association to fractional flow reserve: a DEFINE-FLOW substudy
https://doi.org/10.1136/openhrt-2022-001981
nct02328820 at ClinicalTrials.govDocuments that mention this clinical trial
Prognostic value of microvascular resistance and its association to fractional flow reserve: a DEFINE-FLOW substudy
https://doi.org/10.1136/openhrt-2022-001981
nct02328820 at ClinicalTrials.govDocuments that mention this clinical trial
Prognostic value of microvascular resistance and its association to fractional flow reserve: a DEFINE-FLOW substudy
https://doi.org/10.1136/openhrt-2022-001981
nct02184117 at ClinicalTrials.govDocuments that mention this clinical trial
Prognostic value of microvascular resistance and its association to fractional flow reserve: a DEFINE-FLOW substudy
https://doi.org/10.1136/openhrt-2022-001981
Documents that mention this clinical trial
Prognostic value of microvascular resistance and its association to fractional flow reserve: a DEFINE-FLOW substudy
https://doi.org/10.1136/openhrt-2022-001981
Diabetes does not impact the diagnostic performance of contrast-based fractional flow reserve: insights from the CONTRAST study
https://doi.org/10.1186/s12933-016-0494-2
-
Funding
Funding for this research was provided by:
Philips
- License Information
